Subsequent events (Details) - Strategic Collaboration and License Agreement $ in Millions |
Sep. 03, 2021
USD ($)
item
|
---|---|
Number of therapies to be co-developed | item | 2 |
Number of co-development targets | item | 5 |
Initial period of collaborated research | 8 years |
Number of additional terms | item | 2 |
Number of additional years | 2 years |
Number of years payments are due | 5 years |
Upfront payment received | $ 150 |
Milestone payments | 150 |
Development Milestone | Maximum | |
Milestone payments | 200 |
Development Milestone - Off The Shelf Member T-cell Therapies | Maximum | |
Milestone payments | 100 |
Research Milestone | Maximum | |
Milestone payments | $ 50 |
Commercialisation Milestone | |
Number of co-development targets | item | 5 |
Commercialisation Milestone | Maximum | |
Milestone payments | $ 1,100 |
Sales Milestone | |
Number of co-development targets | item | 5 |
Sales Milestone | Maximum | |
Milestone payments | $ 1,500 |
Regulatory, Sales, And Royalties Milestones | Maximum | |
Milestone payments | $ 800 |
X | ||||||||||
- Definition Initial period of research collaborated research. No definition available.
|
X | ||||||||||
- Definition Represents the amount of milestone payments made by the entity under the license agreement. No definition available.
|
X | ||||||||||
- Definition The number of additional terms. No definition available.
|
X | ||||||||||
- Definition Number of additional years. No definition available.
|
X | ||||||||||
- Definition The number of targets for co-development by the entity and counterparty under the agreement. No definition available.
|
X | ||||||||||
- Definition The number of therapies to be co-development by the entity and counterparty under the agreement. No definition available.
|
X | ||||||||||
- Definition Refers to the number of periods the payments are spread over. No definition available.
|
X | ||||||||||
- Definition Amount of up-front payment received under terms of the agreement. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|